Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers

• Ngā kaituhi matua: Stefan H.E. Kaufmann (Author), January Weiner (Author), Jeroen Maertzdorf (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2017-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Introduction: The most recent estimates on tuberculosis (TB) morbidity and mortality reveal that the global disease burden is even higher than previously assumed. Better drugs, diagnostics and vaccines are major requirements to control the ongoing TB pandemic. The high complexity of the infectious p...